Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Change in Account Payables (2020 - 2025)

Historic Change in Account Payables for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to -$3.9 million.

  • Treace Medical Concepts' Change in Account Payables fell 76944.44% to -$3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.5 million, marking a year-over-year decrease of 12553.92%. This contributed to the annual value of -$1.3 million for FY2024, which is 14145.88% down from last year.
  • Treace Medical Concepts' Change in Account Payables amounted to -$3.9 million in Q3 2025, which was down 76944.44% from $6.7 million recorded in Q2 2025.
  • Over the past 5 years, Treace Medical Concepts' Change in Account Payables peaked at $9.3 million during Q1 2024, and registered a low of -$8.1 million during Q4 2024.
  • For the 5-year period, Treace Medical Concepts' Change in Account Payables averaged around $728315.8, with its median value being $576000.0 (2024).
  • Per our database at Business Quant, Treace Medical Concepts' Change in Account Payables soared by 109832.99% in 2022 and then crashed by 76944.44% in 2025.
  • Over the past 5 years, Treace Medical Concepts' Change in Account Payables (Quarter) stood at $1.6 million in 2021, then tumbled by 51.24% to $787000.0 in 2022, then surged by 300.89% to $3.2 million in 2023, then tumbled by 357.59% to -$8.1 million in 2024, then surged by 52.55% to -$3.9 million in 2025.
  • Its last three reported values are -$3.9 million in Q3 2025, $6.7 million for Q2 2025, and $2.7 million during Q1 2025.